Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12490504 | chr3:108213825 | C/G | 0.000469 | 178 | 24.37 | 43.67 | 10.07 | KM Plot |
PCPG | rs12493634 | chr3:105762869 | C/T | 0.000445 | 175 | 25.97 | 19.85 | 20.08 | KM Plot |
PCPG | rs12515155 | chr5:8025739 | A/T | 8.36E-5 | 170 | 25.53 | 27.2 | 12.15 | KM Plot |
PCPG | rs12578495 | chr12:53503208 | G/A | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs12579710 | chr12:53502999 | T/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs12580912 | chr12:53503224 | A/T | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs12582555 | chr12:26888861 | G/A | 8.74E-5 | 178 | 24.5 | 27.87 | 5.97 | KM Plot |
PCPG | rs125872 | chr1:201635798 | C/T | 1.7E-6 | 178 | 27.4 | 17.4 | 19.3 | KM Plot |
PCPG | rs12596182 | chr16:90022603 | C/T | 1.26E-8 | 172 | 25.67 | 20.2 | 6.62 | KM Plot |
PCPG | rs12596206 | chr16:90022738 | C/T | 1.26E-8 | 172 | 25.67 | 20.2 | 6.62 | KM Plot |
PCPG | rs12596362 | chr16:89582684 | C/T | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs12596492 | chr16:89957169 | T/G | 0.000165 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs12596583 | chr16:90029105 | G/C | 1.09E-8 | 172 | 25.77 | 20.28 | 6.62 | KM Plot |
PCPG | rs12596934 | chr16:89841605 | T/G | 0.000181 | 176 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs12597296 | chr16:89822331 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |